CureBay Raises Rs 100 Crore to Expand Its Rural Clinics

IvyCap Ventures leads the pre-Series C round, which mixes Rs 69 crore of equity with more than Rs 30 crore of debt

Join Us Add as preferred source
Share
CureBay raises Rs 100 crore in pre-Series C funding led by IvyCap Ventures

Key Takeaways

  • CureBay raised about Rs 100 crore in a pre-Series C round led by IvyCap Ventures.
  • The round is Rs 69 crore of equity plus more than Rs 30 crore of debt from Trifecta Capital, Alteria Capital and VentureSoul Partners.
  • CureBay runs 250+ tech-enabled clinics across seven states and has served more than 17 lakh patients.
  • The money goes into new states, including Andhra Pradesh, and better AI health screening.

CureBay, a healthtech startup that brings clinics to villages and small towns, has raised about Rs 100 crore in a pre-Series C round led by IvyCap Ventures.

The money comes in two parts. Rs 69 crore is equity from IvyCap Ventures and existing investors, and more than Rs 30 crore is debt from Trifecta Capital, Alteria Capital and VentureSoul Partners.

CureBay funding at a glance

DetailCureBay pre-Series C
Total raisedAbout Rs 100 crore
EquityRs 69 crore, led by IvyCap Ventures, with existing investors
DebtMore than Rs 30 crore from Trifecta Capital, Alteria Capital and VentureSoul Partners
SectorRural healthtech
Use of fundsNew states, starting with Andhra Pradesh, and better AI health screening

What CureBay does

Most of India's good doctors work in cities, while a large share of patients live far away from them. CureBay tries to close that gap with a chain of tech-enabled clinics in rural and underserved areas.

At a CureBay clinic, a patient can consult a doctor, buy medicines, get diagnostic tests done and get help arranging surgery at a bigger hospital when needed. Instead of travelling to a city for every step, much of the care happens close to home, with technology connecting the patient to the right doctor.

Today the company runs more than 250 clinics across seven states and says it has served over 17 lakh patients.

CureBay's journey so far

WhenMilestone
2021Founded by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain
November 2022Series A of about Rs 50 crore, led by Elevar Equity
January 2024Series A1 of about Rs 62 crore, led by existing investor Elevar Equity
May 2025$21 million Series B led by Bertelsmann India Investments
October 2026About Rs 100 crore pre-Series C led by IvyCap Ventures

What the founder and investor said

"Rural Bharat doesn't need another app; it needs a system that works end to end, from the Swasthya Mitra at the doorstep to the specialist in the city. This capital lets us take that operating system to more states and make our AI do the heavy lifting, so that every family gets the right care at the right time, close to home."

Priyadarshi Mohapatra, founder and CEO, CureBay

"We are excited to partner with CureBay as it scales its reach and continues to make quality healthcare more accessible to underserved communities across the country."

Vikram Gupta, founder and managing partner, IvyCap Ventures

Where the money will go

CureBay will use the funds to take its clinics into new states, with Andhra Pradesh named as the first, and to improve the AI it uses to screen patients and flag health risks early.

Why this deal matters

Healthtech funding in India has mostly gone to apps built for city users. CureBay is a bet on the opposite end of the market: physical clinics in places where good care is hardest to find, made efficient with technology.

The mix of equity and debt is also worth noting. Lenders putting in more than Rs 30 crore suggests they see a business with steady, repeatable operations, not just a growth story.

What to watch next

The key test is whether CureBay can repeat its model in new states, starting with Andhra Pradesh, while keeping clinics well staffed and affordable for rural families.

More funding news

Join Us Add as preferred source
Share

Frequently Asked Questions

How much did CureBay raise in October 2026?

CureBay raised about Rs 100 crore in a pre-Series C round: Rs 69 crore in equity and more than Rs 30 crore in debt.

Who led CureBay's pre-Series C round?

IvyCap Ventures led the round, with existing investors also putting in equity.

Who provided the debt in CureBay's round?

Trifecta Capital, Alteria Capital and VentureSoul Partners provided more than Rs 30 crore of debt.

What does CureBay do?

CureBay runs tech-enabled clinics in rural and underserved areas, offering doctor consultations, medicines, diagnostic tests and surgery support.

How many clinics does CureBay run?

CureBay runs more than 250 clinics across seven states.

How many patients has CureBay served?

CureBay says it has served more than 17 lakh patients.

How will CureBay use the new funding?

It will expand into new states, starting with Andhra Pradesh, and improve its AI health screening.

Who founded CureBay and when?

CureBay was founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain.

How much has CureBay raised before this round?

CureBay raised about Rs 50 crore in its Series A (2022), about Rs 62 crore in a Series A1 (2024) and $21 million in its Series B (2025).

How can patients get care at CureBay?

Patients visit a CureBay clinic in their area, where they can consult a doctor, buy medicines, get diagnostic tests and get help arranging surgery.

How does CureBay use AI?

CureBay uses AI to screen patients and flag health risks early, and it will use part of the new funding to improve that screening.

How do I find CureBay's official website?

CureBay's official website is curebay.com.

More in Funding